Viewing Study NCT04296461


Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2025-12-31 @ 3:30 PM
Study NCT ID: NCT04296461
Status: UNKNOWN
Last Update Posted: 2021-01-22
First Post: 2020-03-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma
Sponsor: UWELL Biopharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: UBP-PCL-P01-3002-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View